Enhabit Q4 net loss $6.4M, adjusted EPS $0.06; FY2024 guidance expects $98-$110M EBITDA

Enhabit, Inc.

Q4 net service revenue $260.6M (-1% YoY); net loss $6.4M vs $95.2M loss in prior year (includes $109M goodwill impairment then).
Home health total admissions +3.9% with non-episodic admissions up 34.2%; revenue down due to payor mix shift of ~$8M.
Hospice revenue +7.8% to $51.1M; adjusted EBITDA doubled to $11.7M on higher revenue per day and cost controls.
FY2024 guidance: net service revenue $1.076B-$1.102B, adjusted EBITDA $98M-$110M, adjusted EPS $0.12-$0.43.
Payor innovation added 11 new Medicare Advantage agreements; 25% of non-episodic visits now under innovation contracts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.